Undalig, Arnel .
HRN: 26-79-98 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/17/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
03/17/2025
03/24/2025
IVTT
1.5gm
Q8H
Tetanus Infection
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominalCentral Nervous System Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes